PDL BIOPHARMA, INC.·4

Oct 1, 8:43 PM ET

PDL BIOPHARMA, INC. 4

4 · PDL BIOPHARMA, INC. · Filed Oct 1, 2014

Insider Transaction Report

Form 4
Period: 2014-09-30
Hart Danny J Jr.
Assoc Genl Counsel/Asst Sec
Transactions
  • Award

    Common stock

    2014-09-30+1,61149,377 total
Footnotes (1)
  • [F1]The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 12, 2015; 16.66% on December 12, 2016; 16.66% on December 12, 2017; and 16.66% on December 12, 2018.

Documents

2 files
  • 4
    wf-form4_141221060292683.xmlPrimary

    FORM 4

  • EX-24

    POWER OF ATTORNEY - /S/ NATHAN N. KRYSZAK, ATTORNEY-IN-FACT FOR DANNY J. HART, JR.